06 December 2019 3 4K Report

Hello all,

Apologies if there is a simple answer to this that I'm just not seeing. I am designing a crispr/cas9 construct and want to use existing plasmids we have as the backbone. I am trying to use a single promoter to drive mcherry and cas9 expression as a single transcript with a t2a skip between them. If I have a second kozak sequence after the t2a skip (so, promoter- kozak-mcherry- t2a-kozak- cas9) will this somehow adversely effect expression? I know generally there is only one kozak sequence at the beginning of the transcript. I can't really get rid of the second kozak sequence in front of the cas9 sequence very easily (long story, restriction enzymes etc).

So would this cause issues in expression?

More Lina Thiel's questions See All
Similar questions and discussions